EP
TSVT

Eversept Partners’s 2seventy bio TSVT Stock Holding History

Eversept Partners’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,003,678
Closed -$2.95M – 71
2024
Q4 		$2.95M Buy
1,003,678
+5,599
+0.6% +$23K 0.26% 50
2024
Q3 		$4.71M Sell
998,079
-109,664
-10% -$495K 0.32% 40
2024
Q2 		$4.26M Sell
1,107,743
-69,935
-6% -$315K 0.29% 50
2024
Q1 		$6.3M Buy
1,177,678
+38,567
+3% +$181K 0.42% 43
2023
Q4 		$4.86M Sell
1,139,111
-314,267
-22% -$966K 0.43% 38
2023
Q3 		$5.7M Buy
+1,453,378
New +$9.53M 0.48% 37

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Eversept Partners's TSVT Position: Q1 2025 in Review

Eversept Partners sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 1,003,678 shares — an estimated $2.95M sold.

Eversept Partners first reported a position in TSVT in Q3 2023 and held it in 6 quarters. The position peaked at $6.3M in Q1 2024. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Eversept Partners reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 1,003,678 2seventy bio shares in Q1 2025, an estimated $2.95M.
  • Eversept Partners first reported a position in 2seventy bio in Q3 2023 and held it in 6 quarters.
  • Eversept Partners's 2seventy bio position peaked at $6.3M in Q1 2024.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.